Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact on +44 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I contacted Zenopa again after a number of years, they took the time to explore what my needs were and suggested a few jobs they were recruiting for.
Bhavna, 2011

Actavis launches Letrozole tablets on first day of patent expiry

4 August 2011 00:00 in Pharmacy Supplier News


Actavis has announced the launch of another product - Letrozole tablets - on the first day of its patent expiry.

The film-coated tablets, which are available in 2.5 mg strength in packs of either 14 or 28, are the seventh pharmaceutical item released by the company so far this year on the day after its patent period ended.

This is the latest in a line of recent launches from Actavis, following hot on the heels of the UK release of ten new medicines, expanding its portfolio in the country to more than 500 products.

Seven line extensions, two off-patent medicines and one new product were among the releases.

These medicines could help Actavis to capitalise on the growing number of prescriptions given out in the UK.

According to statistics from the NHS Information Centre, there has been a 70 per cent increase in the number of prescribed products dispensed over the past ten years.ADNFCR-8000103-ID-800689130-ADNFCR

Other news stories from 04/08/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd